Keutzer Timothy 4
4 · Spero Therapeutics, Inc. · Filed Aug 29, 2024
Insider Transaction Report
Form 4
Keutzer Timothy
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-08-27$1.35/sh−2,213$2,988→ 531,837 total
Footnotes (1)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations pursuant to a "sell to cover" provision included in each RSU Agreement in connection with the vesting of RSUs that were granted to the Reporting Person on August 26, 2021.